Radiopharmaceuticals-lebanon VA medical center

Ended Awarded Last action

Contract number
36C24424N0711
Awardee
Awarding agency
Obligated
$224,078

Award facts

Opportunity
Contract value 100% obligated
$224,077.75 Current and potential, with all options
Completion date 100% complete
Current and potential, with all options
Set-aside
No set-aside
Competition
Competed under SAP Simplified Acquisition
Pricing
Firm Fixed Price
Place of performance
Lebanon, PA 17042, USA

Award details come from SAM.gov/FPDS.

Transactions

Action Obligated Date
Funding Only Action P00005 -$356,382
Supplemental Agreement for work within scope P00004 $0
Supplemental Agreement for work within scope P00003 $1,819
Supplemental Agreement for work within scope P00001 $0
Supplemental Agreement for work within scope P00002 $10,000
Original award $568,641

About this award

The Department of Veterans Affairs, Veterans Integrated Service Network 4 (VISN 4), awarded a delivery order valued at $224,077.75 to Jubilant Draximage Radiopharmacies, Inc., doing business as Jubilant Radiopharma, for the supply of radiopharmaceuticals to the Lebanon VA Medical Center in Pennsylvania. The award, issued on August 1, 2024, with a completion date of July 31, 2025, is structured as a firm fixed-price delivery order with no set-aside designation. Jubilant Radiopharma, a for-profit small disadvantaged business and subsidiary of Jubilant Life Sciences Limited, is the sole prime contractor on this award with no identified subcontractors. The company specializes in manufacturing and distributing specialized medical isotopes and nuclear medicine products essential to diagnostic imaging and therapeutic procedures across the VA healthcare system.

This delivery order is issued under an existing Indefinite Delivery Vehicle (IDV) with VISN 4 valued at $3.06 million, reflecting the VA's ongoing reliance on Jubilant Radiopharma's capabilities for radiopharmaceutical supply. The products delivered under this order support critical nuclear medicine services, including positron emission tomography (PET) scans, cardiac imaging, and cancer treatment diagnostics. Jubilant Radiopharma maintains an extensive portfolio of IDVs across multiple VA regional networks, with contract values ranging from $220,000 to $39.8 million, positioning the company as a key supplier of specialized medical isotopes such as technetium-99m, gallium-68 Dotatate, iodine-123, fluorine-18 fluorodeoxyglucose, and indium-111 pentetreotide to support veterans' access to advanced diagnostic imaging and therapeutic nuclear medicine products nationwide.

Quick answers

Who was awarded contract 36C24424N0711?

36C24424N0711 was awarded to Jubilant Draximage Radiopharmacies, Inc. by Veterans Integrated Service Network 4 (Veterans Health Administration) on August 1, 2024.

How much is contract 36C24424N0711 worth?

The government has obligated $224,078 on 36C24424N0711.

Is contract 36C24424N0711 an order under another contract?

Yes. 36C24424N0711 is a delivery order under 36C24424D0069, an indefinite delivery contract.

Was contract 36C24424N0711 competed?

The extent of competition for 36C24424N0711 was competed under sap.

On GovTribe

See this award's full record

  • Every transaction and funding action
  • The awardee's other awards and teaming partners
  • Similar awards and recompete opportunities
  • Ask GovTribe AI about this award